New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
06:10 EDTCSCredit Suisse names heads of Greater China region, WSJ reports
Credit Suisse (CS) has named Neil Harvey as CEO for Hong Kong, reports the Wall Street Journal. Harvey will be co-CEO of Greater China with Liping Zhang, who maintains his position as vice-chairman in the global investment-banking department. Reference Link
News For CS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2015
06:35 EDTCSCiti plans to rebuild equities franchise, Reuters reports
Citigroup (C) is planning to rebuild its equities franchise in an effort to capitalize on a retrenchment by rivals in the face of new rules created to make the financial system less risky, Reuters reports, citing people familiar with the bank's plans. It may be tough to overcome leaders such as Goldman Sachs (GS), Morgan Stanley (MS), and JPMorgan Chase (JPM), that have long dominated the sector, the report says. Citi is aiming to profit from a retreat of rivals slow to adapt new rules forcing banks to keep more capital, the report says. Deutsche Bank (DB), Credit Suisse (CS), and Barclays (BCS) are among others rebuilding their investment banking businesses, the report adds. Reference Link
06:10 EDTCSBanks lobby EU over privacy rules overhaul, FT reports
Subscribe for More Information
August 27, 2015
06:23 EDTCSGoldman hiring 'several hundred' employees for Warsaw units, Reuters reports
Subscribe for More Information
August 21, 2015
08:40 EDTCSCanadian Security Traders Association to hold a conference
Subscribe for More Information
August 20, 2015
06:07 EDTCSSamsung Bioepis picks Citi, Goldman as lead managers for IPO, Reuters says
Samsung Bioepis has selected Citigroup (C) and Goldman Sachs (GS) as the lead managers for its planned listening on Nasdaq next year, a source tells Reuters. Morgan Stanley (MS) and Credit Suisse (CS) will also take part in the listing for Samsung's (SSNLF) biosimilar drug development arm, the source says. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use